S-亚硝基-N-戊酰基-D，L-青霉胺 | 225233-99-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: S-亚硝基-N-戊酰基-D，L-青霉胺
• 中文别名: S-亚硝基-N-戊酰基-D,L-青霉胺
• 英文名称: S-Nitroso-N-valeryl-D,L-penicillamine
• 英文别名: 3-methyl-3-nitrososulfanyl-2-(pentanoylamino)butanoic acid
• CAS: 225233-99-8
• 化学式: C₁₀H₁₈N₂O₄S
• 分子量: 262.33
• InChiKey: QCRZCAKMRYXQNT-UHFFFAOYSA-N

物化性质

• 熔点：
  98-101°C
• 密度：
  1.25±0.1 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿、甲醇

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  121
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• Compositions and methods for treating metabolic disorders
  申请人：NuSirt Sciences, Inc.

  公开号：US10344002B2

  公开（公告）日：2019-07-09

  Methods and compounds useful for reducing, treating, preventing, or sustaining the reduction of a metabolic disease or disorder are provided herein. Also provided herein are compositions and kits for practicing any of the methods described herein.

  本文提供了用于减少、治疗、预防或持续减少代谢性疾病或紊乱的方法和化合物。本文还提供了用于实施本文所述任何方法的组合物和试剂盒。
• Use of nitric oxide or nitric oxide donor for inducing the production of triacylglycerols in microalgae
  申请人：Commissariat A L'energie Atomique Et Aux Energies Alternatives

  公开号：US10975399B2

  公开（公告）日：2021-04-13

  The invention relates to a method for triggering triacylglycerols (TAG) accumulation in microalgae comprising the step of contacting a source of exogenous nitroxide (NO) with said microalgae in their growth medium.

  本发明涉及一种引发微藻类中三酰甘油（TAG）积累的方法，包括将外源亚硝基氧化物（NO）与生长培养基中的微藻类接触的步骤。
• USE OF NITRIC OXIDE OR NITRIC OXIDE DONOR FOR INDUCING THE PRODUCTION OF TRIACYLGLYCEROLS IN MICROALGAE
  申请人：COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES

  公开号：EP3199620B1

  公开（公告）日：2019-08-21
• COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME DISORDERS
  申请人：CHARLES DREW UNIVERSITY OF MEDICINE AND SCIENCE

  公开号：US20160120890A1

  公开（公告）日：2016-05-05

  The invention provides methods, compositions, uses of compositions, assays and kits for modulating brown adipose tissue (BAT) in animals and patients with obesity, insulin resistance and perturbed glucose homeostasis are disclosed. Accordingly, methods, compositions, uses of compositions, and kits are useful for the amelioration of pathological conditions characterized by storage of excess energy, insulin resistance and related metabolic syndromes often associated with obesity.
• COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS
  申请人：NuSirt Sciences, Inc.

  公开号：US20180105498A1

  公开（公告）日：2018-04-19

  Methods and compounds useful for reducing, treating, preventing, or sustaining the reduction of a metabolic disease or disorder are provided herein. Also provided herein are compositions and kits for practicing any of the methods described herein.